Should drug discovery scientists still embrace the amyloid hypothesis for Alzheimer's disease or should they be looking elsewhere?

Expert Opinion on Drug Discovery
Bruno P ImbimboMark Watling

Abstract

Alzheimer's Disease (AD) represents a large and growing challenge to patients, carers and healthcare systems, yet extensive efforts to develop therapeutics to modify its course have been met with repeated failure in recent decades. Although the evident presence of accumulated β-amyloid (Aβ) in AD brains has singled it out as an obvious therapeutic target, the effective reduction of plaque load or soluble Aβ by numerous drug candidates has not produced commensurate clinical benefits - calling into question the Aβ cascade hypothesis of AD. A similar path is now unfolding in the pursuit of therapeutics targeting hyperphosphorylated tau-comprised neurofibrillary tangles. This perspective reviews the basis of the Aβ cascade hypothesis of AD and how clinical trials of anti-Aβ drugs have failed to support it, and reflects upon the early findings suggesting that a similar path is being followed with therapeutics targeting tau. Other potential approaches to identifying therapeutics for AD are explored herein. The relevance of the Aβ cascade hypothesis to the development of therapeutics for AD appears disproven. Drugs targeting tau appear to be suffering the same fate but may yet produce better results. Alternative approaches are being p...Continue Reading

References

Nov 18, 2005·Neurobiology of Aging·Stephen W ScheffElliott J Mufson
Oct 12, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hani AtamnaBruce N Ames
Jul 11, 2009·Expert Opinion on Investigational Drugs·Bruno P Imbimbo
Sep 3, 2011·Cell·David C RubinszteinGuido Kroemer
Nov 4, 2011·Nature Reviews. Neuroscience·Berislav V Zlokovic
Mar 8, 2012·Nature Reviews. Neuroscience·John H Morrison, Mark G Baxter
Mar 21, 2012·Archives of Neurology·Douglas R GalaskoUNKNOWN Alzheimer’s Disease Cooperative Study
Nov 7, 2012·The Journal of Experimental Medicine·Jungsu KimDavid M Holtzman
Apr 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Philip B VergheseDavid M Holtzman
Dec 18, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Irina LonskayaCharbel E-H Moussa
May 17, 2014·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Anne Brunet, Shelley L Berger
Dec 3, 2014·Neurobiology of Aging·Pedro A DionísioCecília M P Rodrigues
Apr 18, 2015·Brain, Behavior, and Immunity·Anna L MarslandStephen B Manuck
May 27, 2015·Nature Neuroscience·Erik S Musiek, David M Holtzman
Dec 5, 2015·Nature Reviews. Drug Discovery·Knut BiberMarco Prinz
Sep 7, 2016·JAMA Neurology·Jinte MiddeldorpTony Wyss-Coray
Dec 14, 2016·Lancet Neurology·Francesco Panza, Giancarlo Logroscino
Jan 27, 2017·Science Translational Medicine·Sarah L DeVosTimothy M Miller
Feb 12, 2017·Human Molecular Genetics·P Hemachandra ReddyRamesh Kandimalla
Apr 5, 2017·Journal of Alzheimer's Disease : JAD·Chunmei JiangBin Zhao
Apr 12, 2017·Journal of Neurochemistry·Amandine Grimm, Anne Eckert
Jul 4, 2017·Clinical Epigenetics·Raúl Delgado-MoralesMaría Berdasco
Sep 5, 2017·Journal of the American Geriatrics Society·James L KirklandPaul D Robbins
Oct 19, 2017·Journal of Alzheimer's Disease : JAD·Russell H Swerdlow
Dec 8, 2017·Neuron·Chia-Chen LiuGuojun Bu
Jan 6, 2018·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Kristen N WarrenSusan M Resnick
Jan 18, 2018·JAMA Neurology·Liana G ApostolovaUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Feb 8, 2018·Human Gene Therapy. Clinical Development·Jonathan B RosenbergRonald G Crystal
Feb 18, 2018·Scientific Reports·Fabrizio BiundoLuciano D'Adamio
Mar 31, 2018·The Journal of Clinical Investigation·Fan LiaoDavid M Holtzman
Apr 25, 2018·Journal of Alzheimer's Disease : JAD·Aristo VojdaniDatis Kharrazian
Jun 21, 2018·Frontiers in Aging Neuroscience·Holly M BrothersStephen R Robinson

❮ Previous
Next ❯

Citations

Sep 18, 2021·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Bruno P ImbimboClaudia Balducci

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Related Papers

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Gunnar K GourasOskar Hansson
Cold Spring Harbor Perspectives in Medicine
Julia Tcw, Alison M Goate
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Kazuyuki TakataTakashi Taniguchi
© 2021 Meta ULC. All rights reserved